Showing 4601-4610 of 5808 results for "".
- Burt's Bees Nature-Based Ingredients Protect Against Evolving Skincare Challengeshttps://practicaldermatology.com/news/burts-bees-nature-based-ingredients-protect-against-evolving-skincare-challenges/2460772/Burt's Bees bakuchiol bests retinol when it comes to promoting expression of certain anti-aging genes, according to a poster presented at the 2021 American Academy of Dermatology Virtual Meeting Experience. And other new research supports the moisturization and skin barrier benefits
- New Studies Support Taltz’s Role in Treating Psoriasishttps://practicaldermatology.com/news/new-studies-support-taltzs-role-in-treating-psoriasis/2460771/Lilly's Taltz delivers more cumulative days with completely clear skin for adults with psoriasis, compared to seven other biologics. What’s more, Taltz also helped patients stay on treatment longer and have more days without additional therapy in three real-world analyses of U
- Visible Light from the Sun Causes Pigmentary Skin Changeshttps://practicaldermatology.com/news/visible-light-from-the-sun-causes-pigmentary-skin-changes/2460768/Visible light from the sun plays a significant role in causing pigmentary skin changes, particularly in people with skin of color, according to information presented at AAD VMX 2021. “We know from decades of research that unprotected exposure to ultraviolet light from the sun can
- Roflumilast Foam and Cream Show Promise in Multiple Skin Diseaseshttps://practicaldermatology.com/news/roflumilast-foam-and-cream-show-promise-in-multiple-skin-diseases/2460767/Roflumilast foam significantly improved both scalp and body psoriasis, with improvement as early as two weeks after treatment initiation, data presented at the 2021 AAD VMX show. Additionally, data presented in posters at the AAD VMX show that roflumilast foam is a safe, well-tolerated, and effec
- Leo Pharma’s Tralokinumab Produces Sustained Improvement in ADhttps://practicaldermatology.com/news/leo-pharmas-tralokinumab-produces-sustained-improvement-in-ad/2460766/Leo Pharma’s tralokinumab 300 mg every other week plus optional topical corticosteroids (TCS) showed long-term improvements in itch, sleep, and in atopic dermatitis signs and symptoms, according to an interim analysis at 56 weeks in the ECZTEND trial that was presented at the AAD
- UCB’s Bimekizumab Outplays the Competition in Two Phase 3 Psoriasis Trialshttps://practicaldermatology.com/news/ucbs-bimekizumab-outplays-the-competition-in-two-phase-3-psoriasis-trials/2460764/UCB’s Bimekizumab almost entirely cleared moderate to severe psoriasis in more than 60 percent of the patients who took part in two Phase 3 clinical trials. Given via injection under the skin, Bimekizumab is a monoclonal antibody and the first to block both Interleukin 17A and Int
- Thiazide Diuretics Linked to Skin Cancer Riskhttps://practicaldermatology.com/news/thiazide-diuretics-linked-to-skin-cancer-risk/2460744/Use of certain blood pressure-lowering medications may increase risk for skin cancer, a new study shows. Researchers reviewed data for nearly 303,000 adults in Ontario over age 65 who were prescribed medications for high bl
- Practical Dermatology Magazine Mourns the Passing of Two Preeminent Dermatologistshttps://practicaldermatology.com/news/practical-dermatology-mourns-the-passing-of-two-preeminent-dermatologists/2460741/By Wendy Lewis It is with great sadness that Practical Dermatology® magazine pays our respects to two very talented and respected dermatologists, Melanie Grossman, MD and Marta Rendon, MD.
- Now Cleared for Neck Treatments: SkinPen Precisionhttps://practicaldermatology.com/news/skinpen-cleared-for-neck-treatments/2460740/SkinPen® Precision from Crown Aesthetics is now cleared for the treatment of wrinkles on the neck. The FDA clearance is based on results of a recent single-center clinical study, which demonstrated clinical improvement of dermal lines on the neck and high patient satisfaction at one and
- Dermatological Advocates Present Dr. Adam Friedman with Advocacy Leadership Awardhttps://practicaldermatology.com/news/dermatological-advocates-present-dr-adam-friedman-with-advocacy-leadership-award/2460738/The Derma Care Access Network (DCAN), a national non-profit coalition advocating for patient access to optimal dermatological care, is recognizing Adam Friedman, MD with its inaugural Advocacy Leadership Award for his work as a passionate advocate and